Latest News

Lexeo Therapeutics (NASDAQ:LXEO) outlined upcoming clinical and regulatory milestones for its gene therapy programs in Friedreich’s ataxia cardiomyopathy and PKP2-associated arrhythmogenic cardiomyopathy during the Chardan Healthcare Conference. Chief Financial Officer Lou Tamayo said the clinical-

The S&P 500 might be vulnerable to a 20% bear market decline, given the growing number of risks.

Volatility is a recurring theme in this company's story line.

Planet Fitness shares have slumped amid slowing membership growth and AI-related concerns, but analysts see over 30% upside ahead of third-quarter earnings on Nov. 5.

An investment in these three stocks could more than triple in value by 2030.

There’s more to Social Security’s annual cost-of-living adjustment (COLA) than meets the eye.

This under-the-radar mining stock boasts a Superscore of 78 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.

This under-the-radar gold mining stock boasts a Superscore of 75 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.

This under-the-radar copper mining stock boasts a Superscore of 84 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.

This under-the-radar gold mining stock boasts a Superscore of 81 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.

This under-the-radar gold mining stock boasts a Superscore of 71 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.

Veradermics' shares are up nearly 270% since its IPO earlier this year.

If equity markets tumble, the Vanguard Information Technology ETF should be on investors' shopping lists.

It's a red flag investors would rather not see waving, but most of them may not have put this shift in its proper perspective.

New defined outcome ETFs QBKV, SBAR, and XX offer varied buffer, income, and leveraged strategies tied to small caps, options income, and the S&P 500, each with distinct costs and risks.

It's up more than 1,000% over the past three years.

A stock split could boost Micron's stock price by lowering the price per share.

If history is any guide, pain at the pump should not result in pain for Bitcoin investors.

Men's average Social Security benefits exceed women's at every age, a gap rooted in earnings history and survivor-benefit implications.

This under-the-radar mining stock boasts a Superscore of 80 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.

This electric air taxi stock is in recovery mode right now.

Opus Genetics (NASDAQ:IRD) outlined commercialization expectations for its newly approved presbyopia eye drop, progress across its inherited retinal disease gene therapy pipeline and its funding strategy during an investor panel featuring Chief Executive Officer Dr. George Magrath and Chief Financia

Monument Traders Alliance strategists detail a volatility-trading sleeve using IWM, QQQ and GLD options alongside longer-term holdings in Agnico Eagle Mines and Nuveen Municipal Value Fund for income.

The market has crashed before, and it'll probably happen again. So it's best to have a plan ready.

Tilray's transformation is still ongoing, but it just reached a critical milestone.